Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Outstanding (Weighted Average) (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $88.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 8.33% to $88.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $88.5 million through Dec 2025, up 8.33% year-over-year, with the annual reading at $88.5 million for FY2025, 8.33% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $88.5 million in Q4 2025 for IDEAYA Biosciences, roughly flat from $88.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $88.5 million in Q4 2025 to a low of $31.8 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $58.6 million across 5 years, with a median of $53.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 56.84% in 2021 and later increased 8.33% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $35.3 million in 2021, then rose by 17.53% to $41.4 million in 2022, then skyrocketed by 38.79% to $57.5 million in 2023, then soared by 42.0% to $81.7 million in 2024, then grew by 8.33% to $88.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IDYA at $88.5 million in Q4 2025, $88.5 million in Q3 2025, and $88.5 million in Q2 2025.